English  |  正體中文  |  简体中文  |  總筆數 :2828323  
造訪人次 :  32225644    線上人數 :  963
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"hsu c h"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 301-310 / 1656 (共166頁)
<< < 26 27 28 29 30 31 32 33 34 35 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2021-08-31T06:42:28Z �]-Catenin (CTNNB1) mutations are not associated with prognosis in advanced hepatocellular carcinoma Lu L.-C.; Shao Y.-Y.; Lee Y.-H.; Hsieh M.-S.; Hsiao C.-H.; Lin H.-H.; Kao H.-F.; Ma Y.-Y.; Yen F.-C.; ANN-LII CHENG; Hsu C.-H.
臺大學術典藏 2021-08-31T06:42:27Z Long-term disease-free survival achieved by anti-angiogenic therapy plus surgery in a hepatocellular carcinoma patient with extensive liver involvement and lung metastases Shao Y.-Y.; Ho M.-C.; ANN-LII CHENG; Hsu C.-H.
臺大學術典藏 2021-08-31T06:42:23Z Clinical activity of metronomic chemotherapy in liver cancers Shao Y.-Y.; ANN-LII CHENG; Hsu C.-H.
臺大學術典藏 2021-08-31T06:42:23Z Prognosis of patients with advanced hepatocellular carcinoma who failed first-line systemic therapy Shao Y.-Y.; Wu C.-H.; Lu L.-C.; Chan S.-Y.; Ma Y.-Y.; Yen F.-C.; Hsu C.-H.; ANN-LII CHENG
臺大學術典藏 2021-08-31T06:42:22Z A phase i study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies Lin C.-C.; Su W.-C.; Yen C.-J.; Hsu C.-H.; Su W.-P.; Yeh K.-H.; Lu Y.-S.; ANN-LII CHENG; Huang D.C.-L.; Fritsch H.; Voss F.; Taube T.; Yang J.C.-H.
臺大學術典藏 2021-08-31T06:42:19Z Treatment efficacy differences of sorafenib for advanced hepatocellular carcinoma: A meta-analysis of randomized clinical trials Shao Y.-Y.; Shau W.-Y.; Chan S.-Y.; Lu L.-C.; Hsu C.-H.; ANN-LII CHENG
臺大學術典藏 2021-08-31T06:29:49Z Predictive biomarkers of sorafenib efficacy in advanced hepatocellular carcinoma: Are we getting there? Shao Y.-Y.; Hsu C.-H.; ANN-LII CHENG
臺大學術典藏 2021-08-31T06:29:49Z Statin Use Is Associated With Improved Prognosis of Colorectal Cancer in Taiwan Shao Y.-Y.; Hsu C.-H.; Yeh K.-H.; Chen H.-M.; Yeh Y.-C.; Lai C.-L.; Lin Z.-Z.; ANN-LII CHENG; Lai M.-S.
臺大學術典藏 2021-08-31T06:29:49Z High serum transforming growth factor-�]1 levels predict outcome in hepatocellular carcinoma patients treated with sorafenib Lin T.-H.; Shao Y.-Y.; Chan S.-Y.; Huang C.-Y.; Hsu C.-H.; ANN-LII CHENG
臺大學術典藏 2021-08-31T06:29:48Z Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinoma Guo J.-C.; Huang T.-C.; Lin C.-C.; Hsieh M.-S.; Chang C.-H.; Huang P.-M.; Lee J.-M.; Hsu F.-M.; Cheng J.C.-H.; Wang H.-P.; Yeh K.-H.; ANN-LII CHENG; Hsu C.-H.

顯示項目 301-310 / 1656 (共166頁)
<< < 26 27 28 29 30 31 32 33 34 35 > >>
每頁顯示[10|25|50]項目